Probing epitopes on human prorenin during its proteolytic and non-proteolytic activation

被引:18
作者
Deinum, J [1 ]
Derkx, FHM [1 ]
Schalekamp, MADH [1 ]
机构
[1] Univ Hosp Dijkzigt, Dept Internal Med 1, NL-3000 CA Rotterdam, Netherlands
来源
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY | 1998年 / 1388卷 / 02期
关键词
prorenin; propeptide; renin inhibitor; activation; monoclonal antibody; kinetics;
D O I
10.1016/S0167-4838(98)00196-4
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The conformational changes of prorenin (PR) that are associated with its reversible non-proteolytic activation and irreversible proteolytic activation were monitored with immunoradiometric assays, using antibodies against epitopes belonging to the propeptide or the renin part of PR. Binding of PR to the renin inhibitor remikiren or protonation of PR resulted in the slowly progressive and simultaneous expression (t(1/2) congruent to 3.5-5.0 h at 4 degrees C) of epitopes of the N-terminal and C-terminal halves of the propeptide and an epitope that is manifest on renin but not on native non-activated PR. During reversible PR activation-inactivation, expression and disappearance of these epitopes coincided with the appearance and disappearance of enzyme activity. Cleavage of the propeptide from the renin part of PR by plasmin, as demonstrated by the failure of remikiren to unmask the N-terminal and C-terminal propeptide epitopes, was, with some time lag, followed by the simultaneous expression (t(1/2) congruent to 60 min at 4 degrees C) of the renin-specific epitope and enzymatic activity. Based on these findings we propose a model for the non-proteolytic activation of PR that involves the formation of an intermediary form of activated PR with the following properties: (1) the covalently bound propeptide has moved out of the active-site cleft, so that binding sites are exposed to active site ligands, (2) the propeptide is still not in the 'relaxed' conformation that is characteristic for fully, non-proteolytically, activated PR, and (3) the N-terminal part of the renin polypeptide chain has not yet attained the proper location that is required for enzymatic activity. (C) 1998 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:386 / 396
页数:11
相关论文
共 24 条
[1]   IMMUNOLOGICAL EVIDENCE THAT INACTIVE RENIN IS PRORENIN [J].
ATLAS, SA ;
CHRISTOFALO, P ;
HESSON, T ;
SEALEY, JE ;
FRITZ, LC .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1985, 132 (03) :1038-1045
[2]   NEW MONOCLONAL-ANTIBODIES DIRECTED AGAINST THE PROPART SEGMENT OF HUMAN PRORENIN AS A TOOL FOR THE EXPLORATION OF PRORENIN CONFORMATION [J].
COHEN, P ;
SIMON, D ;
BADOUAILLE, G ;
MANI, JC ;
PORTEFAIX, JM ;
PAU, B .
JOURNAL OF IMMUNOLOGICAL METHODS, 1995, 184 (01) :91-100
[3]   X-RAY ANALYSES OF ASPARTIC PROTEINASES .2. 3-DIMENSIONAL STRUCTURE OF THE HEXAGONAL CRYSTAL FORM OF PORCINE PEPSIN AT 2.3-A RESOLUTION [J].
COOPER, JB ;
KHAN, G ;
TAYLOR, G ;
TICKLE, IJ ;
BLUNDELL, TL .
JOURNAL OF MOLECULAR BIOLOGY, 1990, 214 (01) :199-222
[4]  
CUMIN F, 1985, J BIOL CHEM, V260, P154
[5]  
Derkx FHM, 1996, CLIN CHEM, V42, P1051
[6]  
DERKX FHM, 1987, J BIOL CHEM, V262, P2472
[7]   ASYNCHRONOUS CHANGES IN PRORENIN AND RENIN SECRETION AFTER CAPTOPRIL IN PATIENTS WITH RENAL-ARTERY STENOSIS [J].
DERKX, FHM ;
TANTJIONG, L ;
WENTING, GJ ;
BOOMSMA, F ;
TVELD, AJMI ;
SCHALEKAMP, MADH .
HYPERTENSION, 1983, 5 (02) :244-256
[8]  
DERKX FHM, 1992, J BIOL CHEM, V267, P22837
[9]  
DUNN BM, 1978, J BIOL CHEM, V253, P7269
[10]   RO-42-5892 IS A POTENT ORALLY ACTIVE RENIN INHIBITOR IN PRIMATES [J].
FISCHLI, W ;
CLOZEL, JP ;
ELAMRANI, K ;
WOSTL, W ;
NEIDHART, W ;
STADLER, H ;
BRANCA, Q .
HYPERTENSION, 1991, 18 (01) :22-31